HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Alexander Zoufaly Selected Research
Alexander Zoufaly Research Topics
Disease
37
COVID-19
11/2023 - 01/2020
11
Infections
03/2023 - 01/2006
4
Disease Progression
01/2023 - 05/2021
3
Inflammation (Inflammations)
03/2023 - 10/2021
2
Candidemia
03/2024 - 12/2022
2
Neoplasms (Cancer)
01/2023 - 05/2021
2
Breakthrough Infections
10/2022 - 01/2022
2
Pneumonia (Pneumonitis)
12/2021 - 05/2021
2
Anemia
05/2021 - 04/2020
2
Lymphoma (Lymphomas)
01/2018 - 07/2009
2
AIDS-Related Lymphoma (Lymphoma, AIDS Related)
01/2018 - 07/2009
2
Viremia
09/2013 - 07/2009
1
Post-Acute COVID-19 Syndrome
02/2023
1
Bradycardia
01/2023
1
Animal Disease Models
01/2023
1
Delirium
01/2023
1
Superinfection
12/2022
1
Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
04/2022
1
Virus Diseases (Viral Diseases)
01/2022
1
Thromboinflammation
12/2021
1
Thrombophilia
12/2021
1
Myalgia
10/2021
1
Chronic Renal Insufficiency
05/2021
1
Chronic Obstructive Pulmonary Disease (COPD)
05/2021
1
Transfusion Reaction
05/2021
1
Hypersensitivity (Allergy)
05/2021
1
Diabetes Mellitus
05/2021
1
Coronary Artery Disease (Coronary Atherosclerosis)
05/2021
1
Body Weight (Weight, Body)
05/2021
1
Pancreatitis
05/2021
1
Pulmonary Fibrosis (Fibrosing Alveolitis)
05/2021
1
IgA Deficiency
05/2021
Drug/Important Bio-Agent (IBA)
7
Oxygen (Dioxygen)
IBA
08/2023 - 11/2020
5
Antibodies
IBA
01/2022 - 09/2013
4
Antigens
IBA
10/2023 - 01/2021
4
Antiviral Agents (Antivirals)
IBA
01/2023 - 01/2021
3
Peptides (Polypeptides)
IBA
10/2023 - 01/2021
3
Immunoglobulin G (IgG)
IBA
03/2023 - 01/2020
3
sotrovimab
IBA
01/2023 - 10/2022
3
remdesivir
IBA
12/2022 - 11/2020
3
C-Reactive Protein
IBA
05/2021 - 04/2020
2
Autoantigens
IBA
10/2023 - 01/2021
2
Dexamethasone (Maxidex)
FDA Link
Generic
08/2023 - 01/2023
2
Cytokines
IBA
01/2023 - 11/2021
2
N-methyl-valyl-amiclenomycin (BA 2)
IBA
01/2023 - 01/2022
2
N-(2-cyanoethylene)urea (BA 1)
IBA
01/2023 - 01/2022
2
Vaccines
IBA
10/2022 - 01/2022
2
Biomarkers (Surrogate Marker)
IBA
10/2022 - 12/2021
2
Monoclonal Antibodies
IBA
10/2022 - 04/2022
2
RNA (Ribonucleic Acid)
IBA
10/2022 - 01/2021
2
Proteins (Proteins, Gene)
FDA Link
01/2022 - 08/2019
2
Neutralizing Antibodies
IBA
01/2022 - 01/2022
2
Ritonavir (Norvir)
FDA Link
04/2021 - 01/2021
2
Lopinavir
FDA Link
04/2021 - 01/2021
2
Enzymes
IBA
01/2021 - 01/2020
2
Immunoglobulin M (IgM)
IBA
01/2021 - 01/2020
2
Immunosorbents
IBA
01/2021 - 01/2020
1
Angiotensin-Converting Enzyme 2
IBA
11/2023
1
Surface-Active Agents (Surfactants)
IBA
10/2023
1
Pulmonary Surfactant-Associated Protein A (Surfactant Protein A)
IBA
10/2023
1
IgA receptor (protein B)
IBA
10/2023
1
Protein C
IBA
10/2023
1
baricitinib
IBA
08/2023
1
tocilizumab (atlizumab)
FDA Link
08/2023
1
pro-brain natriuretic peptide (1-76)
IBA
02/2023
1
molnupiravir
IBA
01/2023
1
nirmatrelvir
IBA
01/2023
1
Angiotensin I
IBA
11/2022
1
angiotensin I (1-7)
IBA
11/2022
1
Angiotensin II
IBA
11/2022
1
Angiotensins
IBA
11/2022
1
tixagevimab
IBA
10/2022
1
cilgavimab
IBA
10/2022
1
imdevimab
IBA
10/2022
1
Viral RNA
IBA
10/2022
1
Broadly Neutralizing Antibodies
IBA
01/2022
1
mRNA Vaccines
IBA
01/2022
1
Clinitest
IBA
01/2022
1
Messenger RNA (mRNA)
IBA
01/2022
1
Natural Killer Cell Receptors
IBA
01/2022
1
Adenosine Monophosphate (AMP)
IBA
01/2022
1
Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)
IBA
12/2021
1
Cell-Free Nucleic Acids
IBA
12/2021
1
fibrin fragment D (D-dimer)
IBA
12/2021
1
N(4)-oleylcytosine arabinoside
IBA
12/2021
1
Anti-Bacterial Agents (Antibiotics)
IBA
12/2021
1
Oseltamivir (Tamiflu)
FDA Link
12/2021
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
11/2021
1
Interleukin-8 (Interleukin 8)
IBA
11/2021
1
Interleukin-6 (Interleukin 6)
IBA
11/2021
1
Creatine Kinase (Creatine Phosphokinase)
IBA
10/2021
1
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
10/2021
1
Capsules (Microcapsules)
IBA
05/2021
Therapy/Procedure
9
Therapeutics
03/2024 - 01/2018
7
Length of Stay
02/2023 - 01/2021
3
Artificial Respiration (Mechanical Ventilation)
04/2022 - 01/2021
2
Vagus Nerve Stimulation
01/2023 - 01/2022
2
Contraindications
12/2021 - 05/2021
1
Noninvasive Ventilation
11/2021
1
Cannula
05/2021